This latter hypothesis is supported by the fact that patients with CKD usually experience increased MCP-1 plasma levels [75] proportionally to renal damage [76], so this molecule could subsequently concentrate in brain tissue concomitantly with the development of depressive symptoms [77]. Here, CCL2 is linked to chronic kidney disease.